Stephen B. Strum

2.6k total citations · 1 hit paper
42 papers, 1.9k citations indexed

About

Stephen B. Strum is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stephen B. Strum has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Stephen B. Strum's work include Lymphoma Diagnosis and Treatment (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Prostate Cancer Treatment and Research (9 papers). Stephen B. Strum is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Prostate Cancer Treatment and Research (9 papers). Stephen B. Strum collaborates with scholars based in United States, United Kingdom and Netherlands. Stephen B. Strum's co-authors include Henry Rappaport, Mark C. Scholz, Roel A. M. Heesakkers, Johan L. Severens, Yvonne L. Hoogeveen, Eddy Adang, G.J. Jager, Jelle O. Barentsz, Anke M. Hövels and J E McDermed and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen B. Strum

41 papers receiving 1.8k citations

Hit Papers

The diagnostic accuracy of CT and MRI in the staging of p... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen B. Strum United States 21 1.1k 446 409 361 280 42 1.9k
Philip D. Schneider United States 25 563 0.5× 180 0.4× 997 2.4× 129 0.4× 732 2.6× 54 2.2k
Hassan Izzedine France 27 738 0.7× 271 0.6× 275 0.7× 118 0.3× 530 1.9× 94 2.1k
Libni Eapen Canada 24 809 0.7× 116 0.3× 703 1.7× 175 0.5× 384 1.4× 72 1.8k
Richard Choo United States 26 2.1k 1.9× 120 0.3× 651 1.6× 327 0.9× 411 1.5× 114 2.8k
René Baumann France 26 444 0.4× 136 0.3× 485 1.2× 234 0.6× 268 1.0× 90 2.2k
Stéphane Éderhy France 27 525 0.5× 147 0.3× 332 0.8× 283 0.8× 1.3k 4.5× 116 3.0k
Hiroji Uemura Japan 27 1.2k 1.1× 116 0.3× 625 1.5× 276 0.8× 696 2.5× 232 2.7k
Pierluigi Granone Italy 26 1.2k 1.1× 58 0.1× 471 1.2× 373 1.0× 564 2.0× 109 2.6k
Kenneth A. Kern United States 27 664 0.6× 507 1.1× 726 1.8× 176 0.5× 992 3.5× 73 2.7k
Ladislav Pecen Czechia 26 713 0.7× 132 0.3× 424 1.0× 179 0.5× 555 2.0× 132 2.5k

Countries citing papers authored by Stephen B. Strum

Since Specialization
Citations

This map shows the geographic impact of Stephen B. Strum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Strum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Strum more than expected).

Fields of papers citing papers by Stephen B. Strum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen B. Strum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Strum. The network helps show where Stephen B. Strum may publish in the future.

Co-authorship network of co-authors of Stephen B. Strum

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen B. Strum. A scholar is included among the top collaborators of Stephen B. Strum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen B. Strum. Stephen B. Strum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spiliopoulou, Pavlina, Stephen B. Strum, Alexandra Easson, et al.. (2024). 226TiP CLEAR-Me: Interception trial to detect and clear molecular residual disease in patients with high-risk melanoma. Annals of Oncology. 35. S306–S306. 1 indexed citations
2.
Strum, Stephen B.. (2021). Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I. SHILAP Revista de lepidopterología. 1(3). 118–138. 3 indexed citations
3.
Strum, Stephen B.. (2021). Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part II. SHILAP Revista de lepidopterología. 1(3). 139–154. 3 indexed citations
6.
Scholz, Mark C., et al.. (2011). Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer. Clinical Genitourinary Cancer. 9(2). 89–94. 8 indexed citations
7.
Hövels, Anke M., Roel A. M. Heesakkers, Eddy Adang, et al.. (2008). The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clinical Radiology. 63(4). 387–395. 687 indexed citations breakdown →
9.
Scholz, Mark C., et al.. (2006). Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period. The Journal of Urology. 175(5). 1673–1678. 24 indexed citations
10.
Scholz, Mark C., et al.. (2003). Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer and Prostatic Diseases. 6(4). 301–304. 72 indexed citations
11.
Strum, Stephen B., et al.. (2000). Intermittent Androgen Deprivation in Prostate Cancer Patients: Factors Predictive of Prolonged Time Off Therapy. The Oncologist. 5(1). 45–52. 52 indexed citations
12.
Scholz, M., Stephen B. Strum, & J E McDermed. (1999). INTERMITTENT ANDROGEN DEPRIVATION (IAD) WITH FINASTERIDE (F) DURING INDUCTION AND MAINTENANCE PERMITS PROLONGED TIME OFF IAD IN LOCALIZED PROSTATE CANCER (LPC). The Journal of Urology. 156–156. 6 indexed citations
13.
Scholz, Mark C. & Stephen B. Strum. (1999). RE: RECOVERY OF SPONTANEOUS ERECTILE FUNCTION AFTER NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY WITH AND WITHOUT EARLY INTRACAVERNOUS INJECTIONS OF ALPROSTADIL. The Journal of Urology. 161(6). 1914–1915. 7 indexed citations
14.
Strum, Stephen B., J E McDermed, Mark C. Scholz, Henry J. Johnson, & Glenn Tisman. (1997). Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. British Journal of Urology. 79(6). 933–941. 159 indexed citations
15.
Strum, Stephen B.. (1997). Consultation and patient information on the Internet: the patients' forum.. PubMed. 80 Suppl 3. 22–6. 6 indexed citations
16.
Cohen, J. Louis, et al.. (1984). High Pressure Liquid Chromatographic Analysis of Metoclopramide in Serum. Pharmaceutical Research. 1(1). 43–45. 10 indexed citations
17.
Strum, Stephen B., et al.. (1984). Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.. Journal of Clinical Oncology. 2(9). 1057–1063. 12 indexed citations
18.
Strum, Stephen B.. (1982). Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA. 247(19). 2683–2686. 79 indexed citations
19.
Strum, Stephen B., et al.. (1976). Analysis of the conjugated bile acid distribution in human intestinal aspirates using gas liquid chromatography.. PubMed. 6(1). 15–21. 2 indexed citations
20.
Strum, Stephen B. & Henry Rappaport. (1971). The persistence of Hodgkin's disease in long-term survivors. The American Journal of Medicine. 51(2). 222–240. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026